Yahoo Finance Today's Research Reports on Trending Tickers: Cyclacel Pharmaceuticals Inc. and Canadian Solar Inc.
NEW YORK, NY / ACCESSWIRE / July 20, 2017 / U.S. markets reached new record highs Wednesday as better-than-expected earnings from Morgan Stanley helped to strengthen investor optimism for the current earnings season. The Dow Jones Industrial Average gained 0.31 percent to close at a record 21,640.75, while the S&P 500 Index increased 0.54 percent to close at a new all-time high of 2,473.83. The S&P 500 Information Technology Sector closed at 992.29, topping the previous dotcom bubble record of 988.49 set on March 27, 2000. The NASDAQ Composite Index rose 0.64 percent to close at 6,385.04, also a new record high.
"Corporate earnings have been fantastic this quarter, which is shaping up to be one of the best we've had in a long time," said John Bailer, Senior Portfolio Manager at the Boston Company.
RDI Initiates Coverage on:
Cyclacel Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=CYCC
Canadian Solar Inc.
https://ub.rdinvesting.com/news/?ticker=CSIQ
Cyclacel Pharmaceuticals Inc.'s stock fell 40.68% Wednesday, to close the day at $1.75. The stock recorded a trading volume of 5,217,994 shares, which was above its three months average volume of 194,794 shares. In the last year Cyclacel Pharmaceuticals Inc.'s shares have traded in a range of 1.72 - 10.90. The stock is currently trading 83.94% below its 52 week high. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $3.91 is below its 200-day moving average of $4.66. Shares of Cyclacel Pharmaceuticals Inc. have fallen approximately 66.92 percent year-to-date.
Access RDI's Cyclacel Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=CYCC
On Wednesday, shares in Canadian Solar Inc. recorded a trading volume of 3,572,892 shares, which was above the three months average volume of 1,345,420 shares. The stock ended the day 4.00% higher at 17.42. The share price has gained 69.95% from its 52 week low with a 52 week trading range of 10.25 - 18.12.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $14.57 is greater than its 200-day moving average of $13.43. Shares of Canadian Solar Inc. are trading at a Price to Earnings ratio of 34.63. Shares of Canadian Solar Inc. have gained approximately 43.02 percent year-to-date.
Access RDI's Canadian Solar Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=CSIQ
Our Actionable Research on Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) and Canadian Solar Inc. (NASDAQ: CSIQ) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer or a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
